Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Tonix Pharmaceuticals Announces Poster Presentation at the Annual European Congress of Rheumatology (EULAR) 2024
-
Putnam Investments Announces 19(a) Notices For Closed-End Municipal Funds
-
Hamilton ETFs Announces Change to Risk Rating
-
DIRTY JOBS'S MIKE ROWE SHARES JOURNEY TO GOLD OWNERSHIP
-
New Supply and Steady Demand Maintains Rent Growth in May, Reports Yardi Matrix
-
Celerion Honored With Prestigious CRO Leadership Award for Ninth Consecutive Year
-
RedShelf Selected as Digital Content Distribution Provider to The Ohio State University
-
Gen Z's Shift From Tech Careers Spotlights the Need for Soft Skills
-
TerraSource Global Announces the Acquisition of Peninsula Iron Works
-
Amneal Expands Broad Injectables Portfolio to Over 40 Products with the Addition of Six New Therapies
-
Smith Hill Capital and Bain Capital Announce $111 Million Financing for Four-Property Hotel Portfolio
-
MacroFab Announces New Product Offering to Provide Even More Custom Options to Customers
-
ConnectWise Authorized as CVE Numbering Authority by the CVE Program
-
Liminal Secures Additional Funding to Accelerate Generative AI Adoption in Regulated Industries Through Robust Data Protection and Secure Workflow Tooling
-
Smith Foundry Commits to Changing Operations by Spring 2025 in Response to Community Concerns
-
TrinaTracker embraces sustainability at factory in Spain
-
Monroe Street Partners Completes Acquisition of American Roadway Logistics
-
Door Appoints Steve Goldstein as Chief Executive Officer
-
Secure Fit, Effortless Comfort: Shokz Unveils OpenFit Air, Open-Ear True Wireless Earbuds
-
44 Members of Congress Call for Federal Screening Recommendations for Kidney Disease
-
Clene to Present at the Emerging Growth Conference
-
Americhem Announces New Global Sustainability Leader
-
New AI agent for venture capital: 100x cheaper, 5x faster and on-par quality with humans
-
Silo Pharma Announces $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
-
GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test
-
Data Infrastructure Startup Tobiko Data Launches With $21.8 Million in Funding
-
Super League CEO Ann Hand to Participate in H.C. Wainwright Virtual Fireside Chat
-
Akari Therapeutics Announces Interim CEO Employment Contract Demonstrating Alignment with Shareholders
-
ARMLOGI BECOMES AN OFFICIAL AUTHORIZED WAREHOUSER FOR TEMU SELLERS
-
Drucker Alumni Pledge $1 Million to Fellowship Fund, Supporting the Next Generation of Business Leaders
-
Effectv Extends Audience Addressable to Enable Regional and Local Market Advertisers to Deliver Household Targeted Campaigns
-
Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast
-
NFI Buys Brokerage Business Unit of Transfix
-
VS Digital Health Launches Telemedicine Solution That Helps Companies Launch A D2C Healthcare Brand In All 50 States
-
Arcutis Announces Multiple Abstracts, Including Oral Presentation, Accepted at the Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference
-
Talkspace Appoints John Mooney as Chief Product Officer
-
CryptoHeap's New Strategy Aims to Optimize Crypto Staking During Market Fluctuations
-
FIS Launches Climate Risk Financial Modeler to Help Clients Assess, Reduce and Report Risks Tied to Climate Change
-
A UNIQUE EXPLORATION OF GAME WRITING ROLLS INTO THE AMERICAN WRITERS MUSEUM
-
Daxor Corporation Appoints John L. Jefferies, M.D. as Chief Medical Officer
-
Newly Published Peer-Reviewed Article Highlights Advances in Fully Implanted Cochlear Implant Technology
-
Assembly Biosciences Presents New Data Highlighting Hepatitis D Virus Entry Inhibitor ABI-6250 at the EASL Congress™ 2024
-
Astiva Health Summer Gala: An Inaugural Celebration
-
Billor Fulfills the American Dream by Turning Truck Drivers into Entrepreneurs with Fintech and AI
-
Safe Harbor Financial Announces New Small Business Line of Credit Program with the Origination of Three New Lines of Credit
-
Bluejay Therapeutics Presents Positive Preliminary BJT-778 Data from Phase 2 Clinical Trial in Chronic Hepatitis D at EASL 2024 Congress
-
73% of Millennials Plan to Indulge in Self-Gifting This Holiday Season
-
Byrna Technologies Announces Record Preliminary Q2 2024 Results: Revenues Exceed $20 Million; Q2 Production Totals Over 48,000 Units
-
Equip’s Second Annual Report Highlights First-Rate Patient Outcomes, Company Growth
-
Iterum Therapeutics to Present Data at ASM Microbe 2024
